Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma
| Autor: | Tomokazu Sazuka, Akira Kashiwagi, Hiroshi Kitamura, Ario Takeuchi, Sachiyo Murai, Takahiro Kojima, Yoshiaki Yamamoto, Kojiro Ohba, Motohide Uemura, Keita Minami, Hiroshi Nakagomi, Toru Shimazui, Takahiro Osawa, Hiroaki Yasumoto, Masaya Murakami, Ryotaro Tomida, Yoichi M. Ito, Kosuke Ueda, Tomohiko Hara, Yoshihide Kawasaki, Masatoshi Eto, Michinobu Ozawa, Hiroyuki Nishiyama, Nobuo Shinohara, Yasuyuki Miyauchi, Shuichi Morizane, Yasutomo Nakai, Mikio Sugimoto, Daichi Morooka |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Aged
80 and over Oncology medicine.medical_specialty Indazoles Axitinib business.industry Antineoplastic Agents medicine.disease Systemic therapy Kidney Neoplasms Treatment Outcome Second line Renal cell carcinoma Internal medicine medicine Humans Geriatrics and Gerontology business Carcinoma Renal Cell Protein Kinase Inhibitors medicine.drug |
| Zdroj: | Journal of Geriatric Oncology. 12:834-837 |
| ISSN: | 1879-4068 |
| DOI: | 10.1016/j.jgo.2020.12.012 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect